Holen Sie sich die Stockscreener-App
64.49
0.26%
0.17
Schlusskurs vom Vortag:
$64.32
Offen:
$64.2
24-Stunden-Volumen:
2.17M
Relative Volume:
0.96
Marktkapitalisierung:
$14.64B
Einnahmen:
$4.03B
Nettoeinkommen (Verlust:
$789.50M
KGV:
19.37
EPS:
3.33
Netto-Cashflow:
$1.15B
1W Leistung:
+1.98%
1M Leistung:
-8.36%
6M Leistung:
-19.41%
1J Leistung:
-14.94%
1-Tages-Spanne:
$63.76
$64.70
1-Wochen-Bereich:
$62.70
$65.18
52-Wochen-Spanne:
$62.70
$84.67
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
64.49 | 14.64B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Do Options Traders Know Something About Hologic (HOLX) Stock We Don't? - Yahoo Finance
BioZorb Lawsuit - Lawsuit Information Center Blog
Digital X-ray Devices Market Witnessing High Demand | Key Trends - openPR
Fluoroscopy Devices Market Set to Expand | Innovations, - openPR
Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2025: Key Trends, Major Players, Opportunities, Strategies, M&As, 2018-2023, 2028F, 2033F - GlobeNewswire Inc.
Global Stereotactic Breast Biopsy Market Overview, Future - openPR
Hologic Gains CE Mark for Affirm Contrast Biopsy Software - MPO-mag
Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software - Silicon Canals
Can This New Biopsy Technology Transform Breast Cancer Detection in Europe? - StockTitan
Breast Cancer Diagnostic Market: Imaging Advancements, Growth - openPR
Molecular Diagnostics Market: Is Booming Worldwide 2024-2032 | Hologic, Abbott, MDxHealth - openPR
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay - BioSpace
FDA OKs Hologic’s Aptima SARS-CoV-2 Assay - MPO-mag
Hologic's SWOT analysis: diagnostics firm faces growth challenges By Investing.com - Investing.com South Africa
Hologic's SWOT analysis: diagnostics firm faces growth challenges - Investing.com India
These 4 Big Cap Health Care Stocks Just Hit New 52-Week Lows - Forbes
Morcellator Market SWOT Analysis by Key Players- Karl Storz, Hologic, Medtronic - openPR
Cervical Cytology Brushes Market Booming Growth: Future - openPR
Why Hologic (HOLX) Outpaced the Stock Market Today - MSN
Entropy Technologies LP Trims Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Acquired by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires 15,820 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Gynecological Devices Market Projected To Witness Substantial Growth, 2025-2032 | Ethicon, Inc., Hologic, Inc, - EIN News
Leerink Partnrs Has Positive Outlook of Hologic Q4 Earnings - MarketBeat
William Blair Has Pessimistic View of Hologic Q2 Earnings - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Receives $85.77 Consensus Price Target from Analysts - MarketBeat
Hologic (NASDAQ:HOLX) Hits New 1-Year LowWhat's Next? - MarketBeat
HOLX's New Offerings Likely to Revive Stock Amid Macro Woes - MSN
Hologic Stock: Analyst Estimates & Ratings - Nasdaq
Here's Why You Should Retain HOLX Stock in Your Portfolio Now - Nasdaq
Global Access Initiative - Hologic
Biopsy Devices Market Booming Demand, Growth Opportunities, - openPR
Stephens Investment Management Group LLC Has $53.89 Million Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - MSN
North America Diagnostic Imaging Market to Drive Growth with - openPR
Leerink Partnrs Has Pessimistic View of Hologic Q3 Earnings - MarketBeat
William Blair Estimates Hologic's Q3 Earnings (NASDAQ:HOLX) - MarketBeat
Hologic Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Deciphering Hologic (HOLX) International Revenue Trends - Nasdaq
Hologic (NASDAQ:HOLX) Price Target Cut to $85.00 by Analysts at Royal Bank of Canada - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Purchased by Lecap Asset Management Ltd. - MarketBeat
Evercore ISI Has Lowered Expectations for Hologic (NASDAQ:HOLX) Stock Price - MarketBeat
Hologic's (HOLX) Outperform Rating Reaffirmed at Raymond James - MarketBeat
Hologic shares fall 3% as Q2 guidance disappoints - MSN
HOLXHologic Inc Latest Stock News & Market Updates - StockTitan
Breast Health Performance Likely to Aid Hologic's Q1 Earnings - MSN
Hologic, Inc. (NASDAQ:HOLX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Canada Finance
abrdn plc Sells 13,484 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic is Now Oversold (HOLX) - Nasdaq
Hologic, Inc. (NASDAQ:HOLX) Just Reported, And Analysts Assigned A US$80.53 Price Target - Simply Wall St
Hologic outlines Q2 revenue guidance of $995M–$1.005B amid expected diagnostics growth - MSN
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hologic Inc-Aktie (HOLX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mitchell Essex D | Chief Operating Officer |
Dec 04 '24 |
Sale |
76.34 |
24,856 |
1,897,482 |
27,957 |
3.85%
3.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):